Cargando…

A retrospective analysis of the follicle-stimulating hormone starting dose in expected normal responders undergoing their first in vitro fertilization cycle: proposed dose versus empiric dose

OBJECTIVE: The purpose of this retrospective study was to evaluate the appropriateness of various follicle-stimulating hormone (FSH) starting doses in expected normal responders based on the nomogram developed by La Marca et al. METHODS: A total of 117 first in vitro fertilization cycles performed f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Dayong, Han, Soo Jin, Kim, Seul Ki, Jee, Byung Chul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society for Reproductive Medicine 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277670/ https://www.ncbi.nlm.nih.gov/pubmed/30538949 http://dx.doi.org/10.5653/cerm.2018.45.4.183

Ejemplares similares

The effect of aromatase inhibitor letrozole incorporated in gonadotrophin-releasing hormone antagonist multiple dose protocol in poor responders undergoing in vitro fertilization
por: Lee, Kyung-Hee, et al.
Publicado: (2014)

Individualization of the FSH starting dose in IVF/ICSI cycles using the antral follicle count
por: La Marca, Antonio, et al.
Publicado: (2013)

Comparison of corifollitropin alfa and daily recombinant follicle-stimulating hormone in poor responder patients undergoing in vitro fertilization cycles
por: Akarsu, Süleyman, et al.
Publicado: (2017)

Different gonadotropin releasing hormone agonist doses for the final oocyte maturation in high-responder patients undergoing in vitro fertilization/intra-cytoplasmic sperm injection
por: Pabuccu, Emre Goksan, et al.
Publicado: (2015)

Anti-Müllerian Hormone Levels in the Follicular Fluid of the Preovulatory Follicle: A Predictor for Oocyte Fertilization and Quality of Embryo
por: Kim, Jee Hyun, et al.
Publicado: (2014)

Clinical efficacy of dual trigger with human chorionic gonadotropin and a gonadotropin‐releasing hormone agonist for women undergoing fertility preservation
por: Hong, Yeon Hee, et al.
Publicado: (2022)

Effect of Sperm DNA Fragmentation on Embryo Quality in Normal Responder Women in In Vitro Fertilization and Intracytoplasmic Sperm Injection
por: Kim, Su Mi, et al.
Publicado: (2019)

Editorial: Follicle-Stimulating Hormone: Fertility and Beyond
por: Simoni, Manuela, et al.
Publicado: (2019)

Ovarian Response to Different Dose Levels of Follicle Stimulating Hormone (FSH) in Different Genotypes of Bangladeshi Cattle
por: Ali, M. S., et al.
Publicado: (2012)

Cessation of Gonadotropin-Releasing Hormone Antagonist on Triggering Day: An Alternative Method for Flexible Multiple-Dose Protocol
por: Chang, Hye Jin, et al.
Publicado: (2009)

Correlation of Anti-Mullerian Hormone Level and Antral Follicle Count with Oocyte Number in A Fixed-Dose Controlled Ovarian Hyperstimulation of Patients of In Vitro Fertilization Program
por: Permadi, Wiryawan, et al.
Publicado: (2021)

Follicle Stimulating Hormone and Anti-Müllerian Hormone per Oocyte in Predicting in vitro Fertilization Pregnancy in High Responders: A Cohort Study
por: Weghofer, Andrea, et al.
Publicado: (2012)

Radiation Dose-Rate: Engelward and Yanch Respond
por: Engelward, Bevin, et al.
Publicado: (2012)

Empty follicle syndrome
por: Kim, Jee Hyun, et al.
Publicado: (2012)

Radiation dose expected in LHC inner detectors
por: Mouthuy, T
Publicado: (1992)

Pilot study of the optimal protocol of low dose step‐up follicle stimulating hormone therapy for infertile women
por: Matsuzaki, Toshiya, et al.
Publicado: (2018)

GnRH antagonist multiple dose protocol with oral contraceptive pill pretreatment in poor responders undergoing IVF/ICSI
por: Kim, Chung-Hoon, et al.
Publicado: (2011)

Discordance between antral follicle counts and anti-Müllerian hormone levels in women undergoing in vitro fertilization
por: Zhang, Yangyang, et al.
Publicado: (2019)

Efficacy and safety of recombinant human follicle-stimulating hormone in patients undergoing in vitro fertilization-embryo transfer
por: Hu, Linli, et al.
Publicado: (2020)

Oral desensitization to milk: how to choose the starting dose!
por: Mori, Francesca, et al.
Publicado: (2010)

Correlation of oocyte number with serum anti-Müllerian hormone levels measured by either Access or Elecsys in fresh in vitro fertilization cycles
por: Jeong, Hye Gyeong, et al.
Publicado: (2022)

Pretreatment serum human chorionic gonadotropin cutoff value for medical treatment success with single-dose and multi-dose regimen of methotrexate in tubal ectopic pregnancy
por: Kim, Junhwan, et al.
Publicado: (2017)

Application of a warfarin dosing calculator to guide individualized dosing versus empirical adjustment after fixed dosing: a pilot study
por: Cai, Xiaofang, et al.
Publicado: (2023)

Is increasing the dose of Entecavir effective in partial virological responders?
por: Erturk, Ayse, et al.
Publicado: (2014)

Neuropathic pain responds better to increased doses of pregabalin: an in-depth analysis of flexible-dose clinical trials
por: Serpell, Michael, et al.
Publicado: (2017)

Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
por: Tessaro, Irene, et al.
Publicado: (2015)

Original delayed-start ovarian stimulation protocol with a gonadotropin-releasing hormone antagonist, medroxyprogesterone acetate, and high-dose gonadotropin for poor responders and patients with poor-quality embryos
por: Takeuchi, Kazuhiro, et al.
Publicado: (2023)

Cessation of gonadotropin-releasing hormone antagonist on triggering day in flexible multiple-dose protocol: A randomized controlled study
por: Chang, Hye Jin, et al.
Publicado: (2013)

Principles of empiric antimicrobial usage and dosing: Lessons learned
por: Lalonde, Kathryn M., et al.
Publicado: (2022)

Radiation dose expected in LHC inner detectors: an update
por: Mouthuy, T
Publicado: (1993)

Correction for: Efficacy and safety of recombinant human follicle-stimulating hormone in patients undergoing in vitro fertilization-embryo transfer
por: Hu, Linli, et al.
Publicado: (2023)

Editorial: Follicle-stimulating hormone: Fertility and beyond-volume II
por: Simoni, Manuela, et al.
Publicado: (2022)

Tumor growth inhibition modeling to support the starting dose for dacomitinib
por: Fostvedt, Luke K., et al.
Publicado: (2022)

Multicenter, noninterventional, post-marketing surveillance study to evaluate dosing of recombinant human follicle-stimulating hormone using the redesigned follitropin alfa pen in women undergoing ovulation induction
por: Nawroth, Frank, et al.
Publicado: (2015)

Live Birth Rates in Poor Responders’ Group after Previous Treatment with Autologous Platelet-Rich Plasma and Low Dose Ovarian Stimulation Compared with Poor Responders Used Only Low Dose Ovarian Stimulation Before in Vitro Fertilization
por: Stojkovska, Snezhana, et al.
Publicado: (2019)

Pharmacokinetics and Pharmacodynamics of Follicle-Stimulating Hormone in Healthy Women Receiving Single and Multiple Doses of Highly Purified Human Menotrophin and Urofollitrophin
por: Di Stefano, Andrea F. D., et al.
Publicado: (2016)

Phase IV, open-label, randomized study of low-dose recombinant human follicle-stimulating hormone protocols for ovulation induction
por: Serour, Gamal I, et al.
Publicado: (2014)

Luteal Function, Biometrics, and Echotextural Attributes in Santa Inês Ewes Superovulated with Different Total Doses of Porcine Follicle-Stimulating Hormone
por: Bevilaqua, Júlia Ribeiro, et al.
Publicado: (2023)

Ovarian volume and antral follicle count for the prediction of low and hyper responders with in vitro fertilization
por: Kwee, Janet, et al.
Publicado: (2007)

Signal-To-Noise Crossover Dose: Sand et al. Respond
por: Sand, Salomon, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_feq72g6836vi0dsjljb9phlten